Here Are the Facts You Need to Understand MASI

Shares of Health Care sector company Masimo moved 0.3% today, and are now trading at a price of $91.63. The mid-cap stock's daily volume was 17,057 compared to its average volume of 1,008,158. The S&P 500 index returned a -1.0% performance.

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company is based in Irvine and has 4,000 full time employees. Its market capitalization is $4,839,722,496.

8 analysts are following Masimo and have set target prices ranging from $110.0 to $150.0 per share. On average, they have given the company a rating of buy. At today's prices, MASI is trading -29.86% away from its average analyst target price of $130.63 per share.

Over the last year, MASI shares have gone down by -35.0%, which represents a difference of -54.0% when compared to the S&P 500. The stock's 52 week high is $198.0 per share and its 52 week low is $90.87.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023-03-01 29,400 -56,300 85,700 -71.39
2022-02-16 264,600 -34,900 299,500 2.92
2021-02-23 211,100 -79,900 291,000 -1.07
2020-02-19 221,642 -72,492 294,134 14.6
2019-02-26 239,527 -17,126 256,653 149.6
2018-02-28 56,062 -46,763 102,825
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS